The world's first dinosaur-themed glamping retreat invites families to sleep, dine, and dream among prehistoric giants. High-res images here Dinosaurs have been spotted stomping through Dubai, and they've taken over Dubai Parks™ and Resorts! T-REX Glamping is officially open, unveiling the world's first dinosaur-themed glamping retreat, a stay unlike anything else in the region. The […]
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=173382&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your LifeMD, Inc. (NASDAQ:LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=173381&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
KMX STOCK NOTICE: CarMax, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CarMax, Inc. (NYSE: KMX) for potential violations
BAX STOCK NOTICE: Baxter International Inc. Investors with Losses may have been Affected by Fraud – Contact BFA Law before December 15 Lawsuit Deadline GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against
(TSX:APLI),(Pinksheets:APLIF),(PinkSheets:APLIF), HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium on November 20, 2025, in Washington, D.C. The event brings together leaders from government, industry, and academia
(NasdaqGM:NRIX), SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced the pricing of its underwritten registered offering of 24,485,799 shares of its common stock at a price of
Appili Therapeutics to Attend BARDA Innovation Symposium 2025 Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense Innovation GlobeNewswire October 22, 2025 HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced Research
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock GlobeNewswire October 22, 2025 SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced the pricing of its underwritten
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=173390&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or